# abrdn Life Sciences Investors: Form 8-K, filed Sep 12, 2023

- Company: [abrdn Life Sciences Investors](/companies/hql.md) (CIK 884121)
- Form: 8-K
- Filed: 2023-09-12
- Accepted by EDGAR: Sep 12, 2023, 21:06 ET
- Period: 2023-09-06
- Accession: 0001104659-23-100077
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/884121/000110465923100077/tm2325781d2_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/884121/000110465923100077/

## Items reported

- Item 4.01: Change of auditor
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/884121/000110465923100077/tm2325781d2_8k.htm

Filed Sep 12, 2023.
Source: SEC EDGAR, the filing index for accession 0001104659-23-100077. Last ingested by Listed: Oct 24, 2026, 14:58 ET. No prices; not investment advice.